tiprankstipranks
Advertisement
Advertisement

PIII Stock Latest News

P3 Health Partners price target lowered to $3 from $6 at TD Cowen
The FlyP3 Health Partners price target lowered to $3 from $6 at TD Cowen
9d ago
PIII
Maintaining Hold Amid Weak Near-Term Results but Potential Profitability by 2027 for P3
PremiumRatings
Maintaining Hold Amid Weak Near-Term Results but Potential Profitability by 2027 for P3
9d ago
PIII
Morning Movers: AstraZeneca jumps following tozorakimab trial results
PremiumThe Fly
Morning Movers: AstraZeneca jumps following tozorakimab trial results
15d ago
AGX
AZN
P3 Health Partners price target lowered to $4 from $12.50 at Lake Street
PremiumThe Fly
P3 Health Partners price target lowered to $4 from $12.50 at Lake Street
15d ago
PIII
Closing Bell Movers: Argan jumps 10% on earnings beat
PremiumThe Fly
Closing Bell Movers: Argan jumps 10% on earnings beat
15d ago
U
AGX
P3 Health Partners reports Q4 revenue $384.8M, two estimates $357.7M
PremiumThe FlyP3 Health Partners reports Q4 revenue $384.8M, two estimates $357.7M
15d ago
PIII
P3 Health Partners sees FY26 adjusted EBITDA ($20M)-$40M vs. ($161.3M) in FY25
Premium
The Fly
P3 Health Partners sees FY26 adjusted EBITDA ($20M)-$40M vs. ($161.3M) in FY25
15d ago
PIII
P3 Health Partners Signs Long-Term Medicare Advantage Insurer Deal
Premium
Company Announcements
P3 Health Partners Signs Long-Term Medicare Advantage Insurer Deal
16d ago
8K
PIII
Is PIII a Buy, Before Earnings?
PremiumPre-Earnings
Is PIII a Buy, Before Earnings?
18d ago
PIII
P3 Health Partners Extends Availability of Growth Financing
PremiumCompany Announcements
P3 Health Partners Extends Availability of Growth Financing
2M ago
8K
PIII
P3 Health Partners Faces Nasdaq Compliance Challenge
PremiumCompany Announcements
P3 Health Partners Faces Nasdaq Compliance Challenge
4M ago
8K
PIII
P3 Health Partners price target lowered to $12.50 from $20 at Lake Street
PremiumThe Fly
P3 Health Partners price target lowered to $12.50 from $20 at Lake Street
5M ago
PIII
P3 Health Partners Earnings Call Reveals Growth Amid Challenges
PremiumCompany AnnouncementsP3 Health Partners Earnings Call Reveals Growth Amid Challenges
5M ago
PIII
P3 Health Partners Faces Financial Challenges: Hold Rating Amidst Uncertain Profitability Timeline
Premium
Ratings
P3 Health Partners Faces Financial Challenges: Hold Rating Amidst Uncertain Profitability Timeline
5M ago
PIII
P3 Health Partners Reports Q3 2025 Financial Results
Premium
Company Announcements
P3 Health Partners Reports Q3 2025 Financial Results
5M ago
PIII
Cautious Outlook for P3 Health Partners Amid EBITDA Challenges and Capital Needs
PremiumRatings
Cautious Outlook for P3 Health Partners Amid EBITDA Challenges and Capital Needs
5M ago
PIII
P3 Health Partners Forms New MSO with Commonwealth
PremiumCompany Announcements
P3 Health Partners Forms New MSO with Commonwealth
5M ago
8K
PIII
P3 Health Partners raises FY25 revenue view to $1.40-$1.45B from $1.35B-$1.5B
PremiumThe Fly
P3 Health Partners raises FY25 revenue view to $1.40-$1.45B from $1.35B-$1.5B
5M ago
PIII
P3 Health Partners reports Q3 EPS ($9.67), consensus ($6.04)
PremiumThe Fly
P3 Health Partners reports Q3 EPS ($9.67), consensus ($6.04)
5M ago
PIII
PIII Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsPIII Earnings Report this Week: Is It a Buy, Ahead of Earnings?
5M ago
PIII
P3 Health Partners Inc trading resumes
Premium
The Fly
P3 Health Partners Inc trading resumes
7M ago
PIII
P3 Health Partners Inc trading halted, volatility trading pause
Premium
The Fly
P3 Health Partners Inc trading halted, volatility trading pause
7M ago
PIII

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >